Radiation therapy equipment developer RefleXion Medical announced that eight clinical abstracts evaluating the use of its biology-guided radiotherapy (BgRT) technology are being presented during the virtual American Society for Radiation Oncology (ASTRO) 2020 annual meeting.
The abstracts will cover how BgRT can target tumors in various anatomic locations and from several histologies, including non-small cell lung cancer, prostate cancer, and pancreatic cancer.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
